Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Danis

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Emerging Infectious Diseases|April 9, 2008
Chagas disease, FranceFrançois-Xavier Lescure, Ana Canestri, Hugues Melliez, et al.
Blood|May 27, 2014
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisininsStéphane Jauréguiberry, Papa A Ndour, Camille Roussel, et al.
Emerging Infectious Diseases|April 22, 2015
Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2025
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate SynthasePhilip Harrer, Magdalena Krygier, Martin Krenn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trialOumou S Maïga Diakite, Oumou M Maiga, Kassoum Kayentao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 PatientsCamille Roussel, Papa Alioune Ndour, Eric Kendjo, et al.
Science Translational Medicine|July 7, 2017
Measuring the <i>Plasmodium falciparum</i> HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysisPapa Alioune Ndour, Sébastien Larréché, Oussama Mouri, et al.
Malaria Journal|January 29, 2013
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011Myriam Gharbi, Jennifer A Flegg, Véronique Hubert, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Emerging Infectious Diseases|April 9, 2008
Chagas disease, FranceFrançois-Xavier Lescure, Ana Canestri, Hugues Melliez, et al.
Blood|May 27, 2014
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisininsStéphane Jauréguiberry, Papa A Ndour, Camille Roussel, et al.
Emerging Infectious Diseases|April 22, 2015
Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2025
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate SynthasePhilip Harrer, Magdalena Krygier, Martin Krenn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trialOumou S Maïga Diakite, Oumou M Maiga, Kassoum Kayentao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2021
Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 PatientsCamille Roussel, Papa Alioune Ndour, Eric Kendjo, et al.
Science Translational Medicine|July 7, 2017
Measuring the <i>Plasmodium falciparum</i> HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysisPapa Alioune Ndour, Sébastien Larréché, Oussama Mouri, et al.
Malaria Journal|January 29, 2013
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011Myriam Gharbi, Jennifer A Flegg, Véronique Hubert, et al.
Pageof 5